Oxidative stress and anemia in chronic hemodialysis: The promise of bioreactive membranes

Contributions to Nephrology

Volumn 161, Issue , 2008, Pages 89-98

  Cruz, D ^a   De Cal, M ^a   Ronco, C ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL;

ANEMIA; ARTIFICIAL MEMBRANE; CHRONIC KIDNEY FAILURE; HUMAN; OXIDATIVE STRESS; RENAL REPLACEMENT THERAPY; REVIEW;

ANEMIA; HUMANS; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; OXIDATIVE STRESS; RENAL DIALYSIS; VITAMIN E;

EID: 48049122491     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000130413     Document Type: Conference Paper

References (31)

1. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C: Oxidative stress in endstage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272-1280.
2. Taccone-Gallucci M, Lubrano R, Meloni C: Vitamin E as an antioxidant agent. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 32-43.
3. Sasaki M, Hosoya N, Saruhashi M: Development of vitamin E-modified membrane. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 49-70.
4. Uzum A, Toprak O, Gumustas MK, Ciftci S, Sen S: Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis. J Nephrol 2006;19:739-745.
5. Inal M, Kanbak G, Sen S, Akyuz F, Sunal E: Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy. Free Radic Res 1999;31:211-216.
6. Giardini O, Taccone-Gallucci M, Lubrano R, Ricciardi-Tenore G, Bandino D, Silvi I, Paradisi C, Mannarino O, Citti G, Elli M: Effects of α-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients. Clin Nephrol 1984;21:174-177.
7. Németh I, Túri S, Haszon I, Bereczki C: Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis. Pediatr Nephrol 2000;14:13-17.
8. Lu L, Erhard P, Salomon RG, Weiss MF: Serum vitamin E and oxidative protein modification in hemodialysis: a randomized clinical trial. Am J Kidney Dis 2007;50:305-313.
9. Wanner C, Bahner U, Mattern R, Lang D, Passlick-Deetjen J: Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients. Nephrol Dial Transplant 2004;19:2570-2575.
10. Baragetti I, Furiani S, Vettoretti S, et al: Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study. Blood Purif 2006;24:369-376.
11. Girndt M, Lengler S, Kaul H, Sester U, Sester M, Kohler H: Prospective crossover trial of the influence of vitamin-E coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis 2000;35:95-104
12. Sosa MA, Balk EM, Lau J, Liangos O, Balakrishnan VS, Madias NE, Pereira BJ, Jaber BL: A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant 2006;21:2825-2833.
13. Pertosa G, Grandaliano G, Valente M, Montinaro V, Soccio M, Gesualdo L, Schena FP: In vivo evaluation of biocompatibility of a new dialyzer employing the vitamin E-modified cellulose membrane 'Excebrane E': study of mechanisms involved in mononuclear cell activation. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 200-207.
14. Girndt M, Kaul H, Lengler S, Sester U, Sester M, Köhler H: Immunological biocompatibility characterization of a vitamin E-bonded membrane. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 226-242.
15. Yawata Y, Jacobs HS: Abnormal red cell metabolism in patients with chronic uremia: nature of the defect and its persistence despite adequate hemodialysis. Blood 1975;45:231-239.
16. Das N, Das Chowdhury T, Chattopadhyay A, Datta AG: Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. Pol J Pharmacol 2004;56:85-96.
17. Ono K: Effects of large dose vitamin E supplementation on anemia in hemodialysis patients. Nephron 1985;40:440-445.
18. Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorrho R, Descomps B, Canaud B: Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997;12:2312-2317.
19. Sinsakul V, Drake JR, Leavitt JN Jr, Harrison BR, Fitch CD: Lack of effect of vitamin E therapy on the anemia of patients receiving hemodialysis. Am J Clin Nutr 1984;39:223-226.
20. Aguilera A, Teruel JL, Villatruela JJ, Rivera M, Ortuño J: Effect of vitamin E administration on erythropoietin values and anaemia in hemodialysis patients. Nephrol Dial Transplant 1993;8:379.
21. Usberti M, Gerardi G, Micheli A, Tira P, Bufano G, Gaggia P, Movilli E, Cancarini GC, De Marinis S, D'Avolio G, Broccoli R, Manganoni A, Albertin A, Di Lorenzo D: Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. J Nephrol 2002;15:558-564.
22. Usberti M, Gerardi G, Bufano G, Tira P, Micheli A, Albertini A, Floridi A, Di Lorenzo D, Galli F: Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 2002;40:590-599.
23. Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H: Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 2005;20:2775-2782.
24. Kobayashi S, Moriya H, Aso K, Ohtake T: Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int 2003;63:1881-1887.
25. Usberti M, Bufano G, Lima G, Gazzotti RM, Tira P, Gerardi G, Di Lorenzo D: Increased red blood cell survival reduces the need of erythropoietin in hemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 208-214.
26. Taccone-Gallucci M, Meloni C, Lubrano R, Morosetti M, Palombo G, Cianciulli P, Scoppi P, Castello MA, Casciani CU: Chronic haemolysis and erythrocyte survival in haemodialysis patients treated with vitamin E-modified dialysis filters. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 44-48.
27. Nakatan T, Takemoto Y, Tsuchida AK: The effect of vitamin E-bonded dialyzer membrane on red blood cell survival in hemodialyzed patients. Artif Organs 2003;27:214-217.
28. Triolo L, Malaguti M, Ansali F, Comunian MC, Arcangeloni O, Coppolino F, Marrocco F, Sicoli R, Biagini M: Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients. Artif Cells Blood Substit Immobil Biotechnol 2003;31:185-191.
29. Westhuyzen J, Saltissi D, Stanbury V: Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane. Ann Clin Lab Sci 2003;33:3-10.
30. Sasaki M: Development of vitamin E-modified polysulfone membrane dialyzers. J Artif Organs 2006;9:50-60.
31. Al-Jondeby MS, Cabaguing IT, Pajarillo AA, Hawas FA, Mousa DH, Al-Sulaiman MH, Shaheen FA, Al-Khader AA: Comparative crossover controlled study using polysulphone and vitamin E-coated dialyzers. Saudi Med J 2003;24:265-268.